Finance

Beta
Lists
600557:SHA
Jiangsu Kanion Pharmaceutical Co., Ltd.
CNÂ¥12.32
+1.07%
(+0.13) 1D
Jun 5, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600557...
Open
CNÂ¥12.30
High
CNÂ¥12.45
Low
CNÂ¥12.25
Mkt. cap
6.90B
Avg. vol.
6.32M
Volume
2.81M
P/E ratio
23.35
52-wk high
CNÂ¥20.20
52-wk low
CNÂ¥12.08
EPS
CNÂ¥0.53
Shares outstanding
616.45M
No. of employees
5K
Open
CNÂ¥12.30
High
CNÂ¥12.45
Low
CNÂ¥12.25
Mkt. cap
6.90B
Avg. vol.
6.32M
Volume
2.81M
P/E ratio
23.35
52-wk high
CNÂ¥20.20
52-wk low
CNÂ¥12.08
EPS
CNÂ¥0.53
Shares outstanding
616.45M
No. of employees
5K
News stories
From sources across the web
About Jiangsu Kanion Pharmaceutical Co., Ltd.
CEO-
Employees5.38K
Founded1975
Headquarters-
SectorPharmaceutical industry
Websitekanion.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
764.02M
701.11M
950.21M
831.27M
Cost of goods sold
251.45M
237.31M
245.72M
208.06M
Cost of revenue
251.45M
237.31M
245.72M
208.06M
Research and development expenses
114.65M
105.07M
255.97M
128.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
333.28M
303.80M
392.04M
393.78M
Operating expense
459.24M
367.03M
705.97M
529.20M
Total operating expenses
710.68M
604.34M
951.69M
737.26M
Operating income
53.34M
96.77M
-1.48M
94.01M
Other non operating income
-56.40K
-7.70M
8.15M
730.57K
EBT including unusual items
77.00M
72.36M
103.42M
97.61M
EBT excluding unusual items
55.51M
93.42M
10.89M
97.58M
Income tax expense
13.84M
13.37M
3.82M
17.46M
Effective tax rate
17.98%
18.48%
3.69%
17.88%
Other operating expenses
11.30M
-40.43M
58.93M
3.91M
Net income
58.96M
57.27M
104.29M
79.28M
Net profit margin
7.72%
8.17%
10.98%
9.54%
Earnings per share
-
-
-
-
Interest and investment income
5.22M
7.37M
9.43M
6.08M
Interest expense
-2.99M
-3.03M
-5.18M
-3.24M
Net interest expenses
2.23M
4.34M
4.25M
2.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
101.37M
145.87M
44.84M
140.33M
Gain or loss from assets sale
20.48K
-20.48K
-429.20K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more